Amgen price target raised to $329 from $310 at Piper Sandler
Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...
Piper Sandler Keeps Their Buy Rating on Amgen (AMGN)
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
stocknews13h
3 Biotech Stocks Revolutionizing Healthcare
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
Piper Sandler raises Amgen stock price target to $329
Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...
Kinder Morgan discusses multi-billion dollar pipeline expansion across CSRA
One of the largest energy infrastructure companies is rolling out plans to expand a natural gas pipeline in the CSRA.
Novartis1h
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Rockwell Automation Stock Jumps on Earnings. New Orders Helped.
Rockwell reported adjusted earnings per share of $1.83 from sales of $1.9 billion. Wall Street was looking for $1.58 and $1.9 billion, respectively, according to FactSet.